Do neurologists in Germany adhere to the national Parkinson&#39;s disease guideline?

QR Code

Do neurologists in Germany adhere to the national Parkinson&#39;s disease guideline?

Sabrina Schr&ouml;der1, Daniel Kuessner2, Guy Arnold3, York Z&ouml;llner4, Eddie Jones5, Marion Schaefer11Institute of Clinical Pharmacology, Charit&eacute; University Medicine, CCM, Berlin, Germany; 2Basilea Pharmaceutica, Basel, Switzerland; 3Department of Neurology, Sindel...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Sabrina Schr&ouml;der, Daniel Kuessner, Guy Arnold, et al
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2011
Sujets:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/c4824bae047e4a52a59d0c1b88daf525
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Review: management of Parkinson&#39;s disease
par: Pedrosa DJ, et autres
Publié: (2013)

Adjunctive therapy in Parkinson&#39;s disease: the role of rasagiline
par: Gaines KD, et autres
Publié: (2012)

Parkinson&rsquo;s disease patients&rsquo; subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life
par: Skogar &Ouml;, et autres
Publié: (2012)

Sleep disturbances in Parkinson&#39;s disease patients and management options
par: Claassen DO, et autres
Publié: (2011)

Daytime sleepiness in elderly Parkinson&rsquo;s disease patients and treatment with the psychostimulant modafinil: A preliminary study
par: Johan L&ouml;kk
Publié: (2010)

A neurologist’s rhombencephalitis after comirnaty vaccination. A change of perspective
par: Alexander Walter, et autres
Publié: (2021)

Editor&#39;s choice
par: Pinder RM
Publié: (2012)

Psychiatrists’ Understanding and Management of Conversion Disorder: A Bi-National Survey and Comparison with Neurologists
par: Dent B, et autres
Publié: (2020)

Treatment of Parkinson&#39;s disease: nanostructured sol&ndash;gel silica&ndash;dopamine reservoirs for controlled drug release in the central nervous system
par: Tessy L&oacute;pez, et autres
Publié: (2010)

Psychiatric disorders in primary focal dystonia and in Parkinson&rsquo;s disease
par: Fernando MV Dias, et autres
Publié: (2011)

Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem)
par: Fereshtehnejad SM, et autres
Publié: (2013)

Ceruloplasmin and iron in Alzheimer&rsquo;s disease and Parkinson&rsquo;s disease: a synopsis of recent studies
par: Kristinsson J, et autres
Publié: (2012)

Sleep disorders in Parkinson&rsquo;s disease
par: Israt Jahan, et autres
Publié: (2009)

When neurologist and patient disagree on reasonable risk: new challenges in prescribing for patients with multiple sclerosis
par: Kachuck NJ
Publié: (2011)

Parkinson's disease managing reversible neurodegeneration [Corrigendum]
par: Hinz M, et autres
Publié: (2016)

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer&#39;s disease in the Netherlands
par: Hoogveldt B, et autres
Publié: (2011)

Detection of retinal changes in Parkinson&#39;s disease with spectral-domain optical coherence tomography
par: Grant D Aaker, et autres
Publié: (2010)

Did depressive symptoms affect recognition of emotional prosody in Parkinson&rsquo;s disease?
par: Adriana V&eacute;lez Feij&oacute;, et autres
Publié: (2008)

Galantamine treatment in Alzheimer&#39;s disease: response and long-term outcome in a routine clinical setting
par: Wallin &Aring;K, et autres
Publié: (2011)

An update on the toxicity of A&beta; in Alzheimer&rsquo;s disease
par: J&uuml;rgen G&ouml;tz, et autres
Publié: (2008)

Bupropion interferes with the image diagnosis of Parkinson's disease
par: Lin CH, et autres
Publié: (2017)

Economic Impact of Low Adherence to COPD Management Guidelines in Spain
par: Miravitlles M, et autres
Publié: (2021)

The impact of nonmotor symptoms on quality of life in patients with Parkinson's disease in Taiwan
par: Liu WM, et autres
Publié: (2015)

A case of early onset Parkinson's disease after major stress
par: Zou K, et autres
Publié: (2013)

Beneficial effect of pramipexole for motor function and depression in Parkinson&rsquo;s disease
par: Osamu Kano, et autres
Publié: (2009)

Rasagiline in treatment of Parkinson&rsquo;s disease
par: Lakshmi Nayak, et autres
Publié: (2008)

A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder
par: Tr&auml;nkner A, et autres
Publié: (2013)

Psychosocial therapy for Parkinson's-related dementia: intervention development
par: McCormick SA, et autres
Publié: (2017)

The effect of cognitive status and visuospatial performance on affective theory of mind in Parkinson's disease
par: McKinlay A, et autres
Publié: (2013)

Potential sources of stem cells as a regenerative therapy for Parkinson&#39;s disease
par: Abir Oueida El-Sadik
Publié: (2010)

Aberrantly expressed long noncoding RNAs and genes in Parkinson's disease
par: Zhou Y, et autres
Publié: (2018)

Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
par: Xinhua&nbsp;S Ren, et autres
Publié: (2009)

Ventricular orexin-A (hypocretin-1) levels correlate with rapid-eye-movement sleep without atonia in Parkinson's disease
par: Bridoux A, et autres
Publié: (2013)

Dosing frequency and adherence in chronic psychiatric disease: systematic review and meta-analysis
par: Medic G, et autres
Publié: (2013)

Early and Later Perceptions and Reactions to the COVID-19 Pandemic in Germany: On Predictors of Behavioral Responses and Guideline Adherence During the Restrictions
par: Eva Lermer, et autres
Publié: (2021)

Current approaches to the treatment of Parkinson&rsquo;s disease
par: Joseph Jankovic, et autres
Publié: (2008)

Update on ropinirole in the treatment of Parkinson&rsquo;s disease
par: Holly A Shill, et autres
Publié: (2008)

Efficacy and motor complications of original and generic levodopa in Parkinson's disease treatment
par: Kasemsap N, et autres
Publié: (2016)

Fluctuating neurological symptoms: should I call the neurologist or the hematologist?
par: Losa-Rodríguez Rita, et autres
Publié: (2020)

Role and clinical utility of pramipexole extended release in the treatment of early Parkinson's disease
par: Hametner EM, et autres
Publié: (2012)